dry eye disease

OphthaliX Inc. Announces the Completion of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study

OphthaliX Inc. Announces the Completion of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study

Yahoo/PR Newswire

News

Inspire Pharmaceuticals launches drug in Japan

Bizjournals.com

Submitted by moderatora on Fri, 10/08/2010 - 21:58

Device News

TearLab shares soar on Medicare update

The Wall Street Journal

»

4 comments

News

Inspire scuttles eye drug and pencils new deal with Allergan

Fierce Biotech

»

2 comments

News

Inspire Dry Eye Drug Fails Key Test

TheStreet.com

»

Login or register to post comments

News

EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrome

Medical News Today

»

12 comments

News

Ista reports positive results from Phase IIb dry eye trial

Pharmaceutical Business Review

»

Login or register to post comments